Results 331 to 340 of about 22,609,350 (346)

Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood

Proceedings of the National Academy of Sciences of the United States of America, 2016
Katrin Klocke, Shimon Sakaguchi, Rikard Holmdahl   +2 more
exaly  

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

Nature Immunology, 2019
Lawrence P. Andrews, H. Yano, D. Vignali
semanticscholar   +1 more source

CTLA-4-MEDIATEDINHIBITION INREGULATION OFT CELLRESPONSES: Mechanisms and Manipulation in Tumor Immunotherapy

Annual Review of Immunology, 2001
Cynthia A Chambers, Jackson G Egen, James P Allison   +2 more
exaly  

Anti–CTLA-4 therapy requires an Fc domain for efficacy

Proceedings of the National Academy of Sciences of the United States of America, 2018
Jessica R Ingram, Olga S Blomberg, Mohammad Rashidian   +2 more
exaly  

Treg and CTLA-4: Two intertwining pathways to immune tolerance

Journal of Autoimmunity, 2013
Lucy S K Walker
exaly  

CTLA-4 Ablation and Interleukin-12–Driven Differentiation Synergistically Augment Cardiac Pathogenicity of Cytotoxic T Lymphocytes

Circulation Research, 2007
Nir Grabie, Arlene H Sharpe, Andrew Lichtman   +2 more
exaly  

Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation

Journal of Biological Chemistry, 2012
Omar S Qureshi, Satdip Kaur, Tie Zheng Hou   +2 more
exaly  

Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation

Genes and Immunity, 2013
Heather M Gibson
exaly  

CTLA-4 (CD152): A versatile receptor for immune-based therapy

Seminars in Immunology, 2019
Holger Lingel, Monika C Brunner-Weinzierl   +1 more
exaly  

CTLA-4 nanobody stops colitis

Nature Immunology
openaire   +2 more sources